NIAID Plans $20M for New Biodefense Countermeasures, Dx, Rx, Vaccines
February 27, 2013
NIAID Plans $20M for New Biodefense Countermeasures, Dx, Rx, Vaccines
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Luminex Leveraging Advanced Liquid Logic Alliance to Develop Field-based MDx/Immunoassay System
May 16, 2013 / PCR Insider - PositiveID Developing Handheld Version of Cassette-based MDx Platform
May 2, 2013 / PCR Insider - BioFire Diagnostics Wins Contract from US Army to Develop FilmArray Biothreat Detection System
March 28, 2013 / PCR Insider - UK's DSTL Demonstrates Use of Life Tech TaqMan Array Cards to Detect Multiple Biological Agents
May 17, 2012 / PCR Insider - UMDNJ, Cepheid Win $1.3M for Blood-Based Biothreat Tests; Cepheid to Use Tech in MDx Products
March 15, 2012 / PCR Insider